Using Virtual Reality Technology to Improve Patient Experience and Quality of Care During Brachytherapy

Conditions

• Endocervical Cancer

Eligibility Criteria

Sex

FEMALE

Age

18 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• The Oculus Quest 2 Virtual Reality Headset — DEVICE
  The hardware includes the wireless headset with integrated headphones which will block the sight and sounds of the clinical setting as well as the hand controllers for the interactive VR experience, which will be delivered through any of three VR software options (subject may choose one or more from the following options): * Titans of Space® PLUS developed by Drash VR, LLC (Murrieta, CA, USA) * TRIPP® developed by TRIPP, Inc. (Los Angeles, CA, USA) * Nature Treks VR published by Greener Games (Ironbridge, England, UK)

Study Details

The primary objective is to demonstrate the feasibility of incorporating VR distraction into the brachytherapy and radiotherapy clinical workflow. The secondary objective is to determine if VR distraction during brachytherapy treatment for cervical cancer improves subjects' satisfaction, procedural/acute pain, and need for analgesics or anxiolytics.

Key Dates

Start date

Aug 8, 2022

Status verified

Apr 2026

Primary completion

Jul 31, 2027

Completion

Dec 31, 2028

Study Design

Enrollment

20 participants (estimated)

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Arms

• Experimental: Sequence Group A
  VR distraction occurring visits 1 and 2 with normal SOC therapy at visits 3 and 4.
• Experimental: Sequence Group B
  VR distraction occurring visits 1 and 4 with normal SOC therapy at visits 2 and 3.
• Experimental: Sequence Group C
  VR distraction occurring visits 3 and 4 with normal SOC therapy at visits 1 and 2.
• Experimental: Sequence Group D
  VR distraction occurring visits 2 and 3 with normal SOC therapy at visits 3 and 4.

Primary Outcome Measure

The number of eligible subjects who enroll onto the study. [ Time Frame: 3 weeks ]

Central Contacts

• Joseph A Holley
  501-686-8274
  [email protected]
• Vernon Sincere
  501-686-8274
  [email protected]

Locations (1)

Find similar trials in Little Rock, AR